製薬ロボットの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

製薬ロボット市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の製薬ロボット市場規模は2030年までに3億5,790万米ドルに達し、予測期間のCAGRは8.8％成長すると予測されています。

成長の背景には、政府のイニシアチブの急増と、技術進歩に対するヘルスケア支出の増加があります。例えば、日本のロボット戦略は、ロボット技術革新の世界の主要拠点としての日本の確立を目指しています。2022年には、日本政府は9億3,050万米ドルを超える支援を行った。この資金は、製造業、介護・医療、インフラ、農業など、さまざまな主要セクターに分配されました。

さらに、世界各国の政府は、こうした技術的ソリューションがヘルスケアの課題に対処し、患者の転帰を改善する上で変革の可能性を秘めていることを認識しています。したがって、政府の取り組みとヘルスケア支出の増加は、ヘルスケア・モバイル・ロボットの開発と展開を促進すると予想されます。さらに、製薬会社は特許ポートフォリオを強化するために、技術革新以上のことを優先しています。一部の大手製薬会社は、有利なパートナーシップを確保し、業界の進歩の最前線に立つために、戦略的にロボティクスに投資しています。

製造施設における自動化の必要性と新薬の発見における高コストは、創薬、臨床試験、研究所におけるロボット工学の需要を向上させると予測されるその他の要因です。そのため、主要企業は技術的に高度なロボット機械を導入し、市場の成長を促進しています。加えて、自動化とロボット工学は、精度、生産高、迅速なターンアラウンドタイムに対する需要の高まりにより、製薬業界で絶大な人気を得ています。

製薬業界における競争の激化に伴い、医薬品メーカーはロボット技術によって製造工程に革命を起こしつつあります。この技術により製造効率が向上し、高品質な製品を低コストで提供する能力が高まっています。これらの要因により、今後10年間の製造工程における製薬用ロボットの需要に拍車がかかると予想されます。さらに、主要企業はM&Aや協業契約など様々な戦略を実施しており、市場の成長を促進しています。例えば、2023年7月、ABBは協働作用ロボットGoFaの2つの新バリエーションを発売した：GoFa 10とGoFa 12です。これらの追加により、企業はコボットによる自動化を活用する機会が増え、効率が向上します。

製薬ロボット市場レポートハイライト

• 従来型ロボットは、製薬企業が厳しい規制基準やガイドラインを遵守しながら、荷降ろし、包装、パレタイジング、デパレタイジングなどのさまざまなプロセスを合理化し、製品が必要な品質と安全要件を満たすように支援することができます。
• ピッキングとパッケージングセグメントが市場を独占し、予測期間中に最も速いCAGRで成長すると予測されています。
• 2023年には製薬会社が最大のシェアを占めました。同セグメントは予測期間中に最も速い成長が見込まれます。
• アジア太平洋は、多数の大手プレイヤーの存在、支援的な政府の取り組み、製薬業界における自動化の資金調達の増加により、2023年に世界市場を独占しました。
• 2023年3月、韓国のDoosan Robotics Inc.は、中国の自治区である広西チワン族自治区にあるシステムインテグレーション会社Guangxi Pingeとの覚書締結を発表しました。この提携は、協働作用ロボットを使用した医療ソリューションの開発・販売に重点を置くものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 製薬ロボット市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 製薬ロボット市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • ケーススタディ分析

第4章 製薬ロボット市場：製品推定・動向分析

• セグメントダッシュボード
• 製薬ロボット市場：製品変動分析、2023年および2030年
• 従来型ロボット
• 協働ロボット

第5章 製薬ロボット市場：用途の推定・動向分析

• セグメントダッシュボード
• 製薬ロボット市場：用途変動分析、2023年および2030年
• ピッキング・包装
• 医薬品の検査
• ラボ用途

第6章 製薬ロボット市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 製薬ロボット市場：最終用途変動分析、2023年および2030年
• 製薬会社
• 研究ラボ

第7章 製薬ロボット市場：地域の推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模、予測トレンド分析、2018年から2030年：
• 北米
  • 北米： SWOT分析
  • 米国
  • カナダ
• 欧州
  • 欧州：SWOT分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • アジア太平洋：SWOT分析
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ： SWOT分析
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ：SWOT分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 企業の市場ポジション分析、2023年
  • Kawasaki Heavy Industries, Ltd.
  • FANUC America Corporation（FANUC Corporation）
  • ABB
  • Yaskawa Electric Corporation
  • Denso Wave Incorporated（Denso Corporation）
  • Seiko Epson Corporation
  • Marchesini Group SpA
  • Kuka AG
  • Mitsubishi Electric Corporation
  • Shibuya Corporation

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 North America pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 4 North America pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 5 North America pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 6 U.S. pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 9 Canada pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 12 Europe pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 13 Europe pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 14 Europe pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 15 UK pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 16 UK pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 17 UK pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 18 Germany pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 19 Germany pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 20 Germany pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 21 France pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 22 France pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 23 France pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Italy pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 25 Italy pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 26 Italy pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 27 Spain pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 28 Spain pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 29 Spain pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 30 Sweden pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 31 Sweden pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 32 Sweden pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Denmark pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 34 Denmark pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 35 Denmark pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Norway pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 37 Norway pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 38 Norway pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 39 Asia Pacific pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 42 Japan pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 43 Japan pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 44 Japan pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 45 China pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 46 China pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 47 China pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 48 India pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 49 India pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 50 India pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 51 Australia pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 52 Australia pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 53 Australia pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 54 South Korea pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 55 South Korea pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 56 South Korea pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Thailand pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 58 Thailand pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 59 Thailand pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 60 Latin America pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 61 Latin America pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 62 Latin America pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 63 Brazil pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 64 Brazil pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 65 Brazil pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Mexico pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 67 Mexico pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 68 Mexico pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Argentina pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 70 Argentina pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 71 Argentina pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 72 MEA pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 73 MEA pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 74 MEA pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 75 South Africa pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 76 South Africa pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 77 South Africa pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 78 Saudi Arabia pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 79 Saudi Arabia pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 80 Saudi Arabia pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 81 UAE pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 82 UAE pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 83 UAE pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)
• Table 84 Kuwait pharmaceutical robots market, by product, 2018 - 2030 (USD Million)
• Table 85 Kuwait pharmaceutical robots market, by application, 2018 - 2030 (USD Million)
• Table 86 Kuwait pharmaceutical robots market, by end-use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Pharmaceutical robots: market outlook

Fig. 9 Pharmaceutical robots competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook.

Fig. 12 Pharmaceutical robots driver impact

Fig. 13 Pharmaceutical robots restraint impact

Fig. 14 Pharmaceutical robots strategic initiatives analysis

Fig. 15 Pharmaceutical robots: Product Type movement analysis

Fig. 16 Pharmaceutical robots: Product Type outlook and key takeaways

Fig. 17 Traditional robots market estimates and forecasts, 2018 - 2030

Fig. 18 Collaborative robots market estimates and forecasts, 2018 - 2030

Fig. 19 Articulated robots market estimates and forecasts, 2018 - 2030

Fig. 20 SCARA robots market estimates and forecasts, 2018 - 2030

Fig. 21 Delta/Parallel robots market estimates and forecasts, 2018 - 2030

Fig. 22 Cartesian robots market estimates and forecasts, 2018 - 2030

Fig. 23 Dual-arm robots market estimates and forecasts, 2018 - 2030

Fig. 24 Pharmaceutical robots: Application movement analysis

Fig. 25 Pharmaceutical robots: Application outlook and key takeaways

Fig. 26 Picking and packaging market estimates and forecasts, 2018 - 2030

Fig. 27 Inspection of pharmaceutical drugs market estimates and forecasts, 2018 - 2030

Fig. 28 Laboratory applications market estimates and forecasts, 2018 - 2030

Fig. 29 Pharmaceutical robots: End-use movement analysis

Fig. 30 Pharmaceutical robots: End-use outlook and key takeaways

Fig. 31 Pharmaceutical companies market estimates and forecasts, 2018 - 2030

Fig. 32 Research laboratories market estimates and forecasts, 2018 - 2030

Fig. 33 Global pharmaceutical robots market: Regional movement analysis

Fig. 34 Global pharmaceutical robots market: Regional outlook and key takeaways

Fig. 35 North America pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 36 Key country dynamics

Fig. 37 U.S. pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 38 Key country dynamics

Fig. 39 Canada pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 40 Europe pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 41 Key country dynamics

Fig. 42 UK pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 43 Key country dynamics

Fig. 44 Germany pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 45 Key country dynamics

Fig. 46 Spain pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 47 Key country dynamics

Fig. 48 France pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 49 Key country dynamics

Fig. 50 Italy pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD millio0)

Fig. 51 Key country dynamics

Fig. 52 Norway pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 53 Key country dynamics

Fig. 54 Denmark pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 55 Key country dynamics

Fig. 56 Sweden pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 57 Asia Pacific pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 58 Key country dynamics

Fig. 59 Japan pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 60 Key country dynamics

Fig. 61 China pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 62 Key country dynamics

Fig. 63 India pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 64 Key country dynamics

Fig. 65 Australia pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 66 Key country dynamics

Fig. 67 South Korea pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 68 Key country dynamics

Fig. 69 Thailand pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 70 Latin America pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 71 Key country dynamics

Fig. 72 Brazil pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 73 Key country dynamics

Fig. 74 Mexico pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 75 Key country dynamics

Fig. 76 Argentina pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 77 MEA pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 78 Key country dynamics

Fig. 79 South Africa pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 80 Key country dynamics

Fig. 81 Saudi Arabia pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 82 Key country dynamics

Fig. 83 UAE pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 84 Key country dynamics

Fig. 85 Kuwait pharmaceutical robots market estimates and forecasts, 2018 - 2030 (USD Million)

Pharmaceutical Robots Market Growth & Trends:

The global pharmaceutical robots market size is expected to reach USD 357.9 million by 2030, growing a CAGR of 8.8% over the forecast period, according to a new report by Grand View Research, Inc. Growth can be attributed to the surge in government initiatives and increase in healthcare spending on technological advancements. For instance, Japan's Robot Strategy aims to establish the country as the premier hub for robot innovation globally. In 2022, the Japanese government provided over USD 930.5 million in support. This funding was distributed across various key sectors, such as manufacturing, nursing & medical, infrastructure, and agriculture.

Moreover, governments worldwide recognize these technological solutions have transformative potential in addressing healthcare challenges and improving patient outcomes. Hence, the rise in the number of government initiatives and healthcare spending is expected to propel the development and deployment of healthcare mobile robots. Furthermore, pharmaceutical companies prioritize more than just innovation to boost their patent portfolios. Some of the leading pharmaceutical companies are strategically investing in robotics to secure lucrative partnerships and position themselves at the forefront of industry advancements.

The need for automation in manufacturing facilities and the high costs of discovering new drugs are the other factors predicted to improve the demand for robotics in drug discovery, clinical trials, & laboratories. Hence, key companies have introduced technologically advanced robotic machines, propelling market growth. In addition, automation and robotics have gained immense popularity in the pharmaceutical industry due to the growing demand for precision, output, & faster turnaround times.

With the growing competition in the pharmaceutical industry, drug manufacturers are revolutionizing manufacturing processes with robotic technology. This technology has increased manufacturing efficiency and a growing ability to offer quality products at lower costs. These factors are expected to fuel the demand for pharmaceutical robots for manufacturing processes in the coming decade. Furthermore, key players are undertaking various strategies, such as mergers & acquisitions and collaborative agreements, facilitating market growth. For instance, in July 2023, ABB launched two new variants of its GoFa collaborative robot: The GoFa 10 and GoFa 12. These additions would provide companies with enhanced opportunities to utilize cobot automation, boosting efficiency.

Pharmaceutical Robots Market Report Highlights:

• The traditional robots segment dominated the market with the largest share in 2023.Traditional robots can help pharmaceutical companies streamline various processes, such as unloading, packaging, palletizing, & depalletizing, while adhering to strict regulatory standards and guidelines, ensuring that their products meet the necessary quality and safety requirements.
• The picking and packaging segment dominated the market and is anticipated to grow at the fastest CAGR over the forecast period.
• The pharmaceutical companies accounted for the largest share in 2023. The segment is expected to witness the fastest growth over the forecast period.
• Asia Pacific dominated the global market in 2023 due to the presence of a large number of major players, supportive government initiatives, and increasing funding of automation in the pharmaceutical industry.
• Some of the key players in the market are ABB Ltd.; Kawasaki Heavy Industries Ltd.; Universal Robots A/S; FANUC America Corporation; Yaskawa Electric Corporation, Mitsubishi Electric Corporation, and Shibuya Corporation. Emerging players are adopting key strategic initiatives to expand their business footprint and grow their clientele.
• For instance, in March 2023, Doosan Robotics Inc., a South Korean company, announced the signing of a memorandum of understanding with Guangxi Pinge, a system integration firm located in Guangxi, an autonomous region of China. This partnership would focus on developing and selling medical solutions using collaborative robots.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application Outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Pharmaceutical Robots Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Pharmaceutical Robots Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. Case Study Analysis

Chapter 4. Pharmaceutical Robots Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pharmaceutical Robots Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.2.1. Traditional Robots
    • 4.2.1.1. Traditional Robots Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.2. Articulated robots
    • 4.2.1.2.1. Articulated robots Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.3. SCARA robots
    • 4.2.1.3.1. SCARA robots Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.4. Delta/Parallel robots
    • 4.2.1.4.1. Delta/Parallel robots Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.5. Cartesian robots
    • 4.2.1.5.1. Cartesian robots Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.1.6. Dual-arm Robots
    • 4.2.1.6.1. Dual-arm robots Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.2.2. Collaborative Robots
    • 4.2.2.1. Collaborative Robots Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Robots Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pharmaceutical Robots Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.2.1. Picking and Packaging
    • 5.2.1.1. Picking and packaging Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.2. Inspection of Pharmaceutical Drugs
    • 5.2.2.1. Inspection of Pharmaceutical Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.2.3. Laboratory Applications
    • 5.2.3.1. Laboratory Applications Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Robots Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pharmaceutical Robots Market: End-use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.2.1. Pharmaceutical Companies
    • 6.2.1.1. Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2.2. Research Laboratories
    • 6.2.2.1. Research Laboratories Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Robots Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. North America: SWOT Analysis
  • 7.5.2. U.S.
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe: SWOT Analysis
  • 7.6.2. UK
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Regulatory framework
    • 7.6.9.3. Competitive scenario
    • 7.6.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific: SWOT Analysis
  • 7.7.2. Japan
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.5. Australia
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.6. South Korea
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Regulatory framework
    • 7.7.7.3. Competitive scenario
    • 7.7.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America: SWOT Analysis
  • 7.8.2. Brazil
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8.3. Mexico
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8.4. Argentina
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. MEA: SWOT Analysis
  • 7.9.2. South Africa
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key country dynamics
    • 7.9.5.2. Regulatory framework
    • 7.9.5.3. Competitive scenario
    • 7.9.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Company Market Position Analysis, 2023
  • 8.3.2. Kawasaki Heavy Industries, Ltd.
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. FANUC America Corporation (FANUC Corporation)
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. ABB
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Yaskawa Electric Corporation
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Denso Wave Incorporated (Denso Corporation)
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Seiko Epson Corporation
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Marchesini Group S.p.A
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Kuka AG
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Mitsubishi Electric Corporation
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Shibuya Corporation
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Product Benchmarking
    • 8.3.11.4. Strategic initiatives